Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Novartis Pharmaceuticals
Non-Hodgkin Lymphoma
United States, Australia, Austria, Belgium, Brazil +13 more
Sponsor: H. Lundbeck A/S
Migraine
United States, Bulgaria, Czechia, Denmark, France +9 more
Sponsor: Eli Lilly and Company
Alzheimer Disease
United States, Australia, Canada, Japan, Poland
- A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to GrowActive Not Recruiting
Sponsor: Novo Nordisk A/S
SGA, Turner Syndrome, Noonan Syndrome, ISS
United States, Austria, Belgium, Brazil, Bulgaria +28 more
Sponsor: Kite, A Gilead Company
Large B-cell Lymphoma · Follicular Lymphoma
United States, Japan
- Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple MyelomaActive Not Recruiting
Sponsor: GlaxoSmithKline
Multiple Myeloma
United States, Australia, Brazil, China, Czechia +13 more
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Brazil, Canada, China, France +10 more
- A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety InformationEnrolling By Invitation
Sponsor: Novo Nordisk A/S
Adult Growth Hormone Deficiency
United States, France, Germany, Japan, Saudi Arabia +1 more
Sponsor: Celgene
Lymphoma, T-Cell
Japan
Sponsor: Sanofi
Crohn's Disease
United States, Argentina, Australia, Brazil, Bulgaria +19 more
- All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple MyelomaActive Not Recruiting
Sponsor: GlaxoSmithKline
Multiple Myeloma
Japan
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Arthritis, Rheumatoid
United States, Canada, Chile, China, Colombia +6 more
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsActive Not Recruiting
Sponsor: Novo Nordisk A/S
Haemophilia A With Inhibitors · Haemophilia B With Inhibitors
United States, Algeria, Australia, Austria, Bulgaria +24 more
Sponsor: AbbVie
Multiple Myeloma
United States, France, Japan, Spain
- A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction TherapyActive Not Recruiting
Sponsor: AbbVie
Acute Myeloid Leukemia (AML)
United States, Australia, Austria, Belgium, Brazil +24 more
Sponsor: GlaxoSmithKline
Respiratory Syncytial Virus Infections
United States, Australia, Canada, Germany, Italy +3 more
Sponsor: AbbVie
Migraine
Japan
Sponsor: Merck Sharp & Dohme LLC
Warts, Genital · Neoplasms, Anal
Japan
Sponsor: Novartis Pharmaceuticals
Secondary Malignancies of T-cell Origin
Japan
Sponsor: Pfizer
EGFR Mutation-positive Inoperable or Reccrent NSCLC
Japan
- A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular AtrophyActive Not Recruiting
Sponsor: Hoffmann-La Roche
Spinal Muscular Atrophy (SMA)
United States, Australia, Belgium, Canada, Croatia +7 more
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive Not Recruiting
Sponsor: Pfizer
Neoplasms
United States, Argentina, Australia, Belgium, Brazil +24 more
- Treatment Strategy for Patients With RA-ILDNot Yet Recruiting
Sponsor: Chinese SLE Treatment And Research Group
Rheumatoid Arthritis Associated Interstitial Lung Disease
China
- Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored StudyActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
ALK Positive Malignancies
United States, Australia, Belgium, Brazil, Bulgaria +16 more
- First in Human Study of AZD9592 in Solid TumorsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Solid Tumours · Carcinoma Non-small Cell Lung · Head and Neck Neoplasms · Colorectal Neoplasms
United States, Australia, Canada, China, France +6 more